Skip to main content

Advertisement

SpringerLink
Log in

MUCOSAL IMMUNOLOGY

Get the IL-17F outta here!

  • News & Views
  • Published:

From Nature Immunology

View current issue Submit your manuscript

A Publisher Correction to this article was published on 01 February 2019

This article has been updated

The cytokine IL-17F constrains the growth of immunoregulatory Clostridium cluster XIVa species and represents a potential therapeutic target for the treatment of inflammatory bowel disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1: Modulation of gut microbiota by IL-17F.

Marina Corral Spence/Springer Nature

Change history

  • 01 February 2019

    In the version of this article initially published, a word (“neutraling”) in sentence 2 of paragraph 5 is incorrect. The correct phrase is “...neutralizing properties...”. The error has been corrected in the HTML and PDF version of the article.

References

  1. Tang, C. et al. Nat. Immunol. https://doi.org/10.1038/s41590-018-0134-y (2018).

  2. Ahern, P. P., Izcue, A., Maloy, K. J. & Powrie, F. Immunol. Rev. 226, 147–159 (2008).

    Article  Google Scholar 

  3. Lowes, M. A., Russell, C. B., Martin, D. A., Towne, J. E. & Krueger, J. G. Trends Immunol. 34, 174–181 (2013).

    Article  CAS  Google Scholar 

  4. Targan, S. R. et al. Am. J. Gastroenterol. 111, 1599–1607 (2016).

    Article  CAS  Google Scholar 

  5. Hueber, W. et al. Gut 61, 1693–1700 (2012).

    Article  CAS  Google Scholar 

  6. Sands, B. E. et al. Gastroenterology 153, 77–86.e6 (2017).

    Article  CAS  Google Scholar 

  7. Feagan, B. G. et al. Lancet 389, 1699–1709 (2017).

    Article  CAS  Google Scholar 

  8. Maxwell, J. R. et al. Immunity 43, 739–750 (2015).

    Article  CAS  Google Scholar 

  9. Miossec, P. & Kolls, J. K. Nat. Rev. Drug Discov. 11, nrd3794 (2012).

    Article  Google Scholar 

  10. Atarashi, K. et al. Science 331, 337–341 (2011).

    Article  CAS  Google Scholar 

  11. Paramsothy, S. et al. J. Crohn’s Colitis 11, 1180–1199 (2017).

    Article  Google Scholar 

  12. Fuentes, S. et al. ISME J. 11, 1877–1889 (2017).

    Article  Google Scholar 

  13. Paramsothy, S. et al. Lancet 389, 1218–1228 (2017).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Janssen Immunology Research and Development, Spring House, PA, USA

    Aisling O’Hara Hall & Scott E. Plevy

  2. Janssen Immunology Research and Development, San Diego, CA, USA

    Jennifer E. Towne

Authors
  1. Aisling O’Hara Hall
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jennifer E. Towne
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Scott E. Plevy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Scott E. Plevy.

Ethics declarations

Competing interests

A.O.H., J.E.T. and S.E.P. are employed by Janssen Pharmaceutical Companies of Johnson and Johnson.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hall, A.O., Towne, J.E. & Plevy, S.E. Get the IL-17F outta here!. Nat Immunol 19, 648–650 (2018). https://doi.org/10.1038/s41590-018-0141-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41590-018-0141-z

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation